Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Gottlieb's Complex Generics Remarks Could Signal (Some) Increased Flexibility

Nov 29 2017

• By Michael Cipriano

Related Content

Complex ANDAs: Early Meetings With FDA Can Generate Bonus Communication

Oct 03 2017

Complex Generics: Gottlieb Eyes FDA Policy Changes To Speed Approvals

Apr 06 2017

ANDAs For Drug/Device Combos Face High Bar At US FDA; Epipen, Advair May Benefit

Jan 17 2017

Gottlieb Places Drug Pricing Out Front In First Speech To US FDA Staff

May 16 2017

Additional Topics

United States Generic Drugs FDA Regulation BioPharmaceutical

More from Generics

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window